An outbreak of novel psychoactive substance benzodiazepines in the unregulated drug supply: Preliminary results from a community drug checking program using point-of-care and confirmatory methods

Designer benzodiazepines’ pharmacological effects and potencies: How to find the information

(2020) Souleiman El Balkhi et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Trusting the source: The potential role of drug dealers in reducing drug-related harms via drug checking

(2019) Geoff Bardwell et al.   DRUG AND ALCOHOL DEPENDENCE

An expanding world of new psychoactive substances—designer benzodiazepines

(2019) Jolanta B. Zawilska et al.   NEUROTOXICOLOGY

Drug checking services at music festivals and events in a Canadian setting

(2019) Karen McCrae et al.   DRUG AND ALCOHOL DEPENDENCE

Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting

(2018) Kenneth W. Tupper et al.   DRUG AND ALCOHOL DEPENDENCE

Occurrence and time course of NPS benzodiazepines in Sweden – results from intoxication cases in the STRIDA project

(2018) Matilda Bäckberg et al.   CLINICAL TOXICOLOGY

Designer benzodiazepines: a report of exposures recorded in the National Poison Data System, 2014–2017

(2018) Joseph E. Carpenter et al.   CLINICAL TOXICOLOGY

Clinical Interpretation of Urine Drug Tests

(2017) Karen E. Moeller et al.   MAYO CLINIC PROCEEDINGS

The cutting of cocaine and heroin: A critical review

(2016) Julian Broséus et al.   FORENSIC SCIENCE INTERNATIONAL

Flumazenil, naloxone and the ‘coma cocktail’

(2015) Marco L.A. Sivilotti   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Flubromazolam – A new life-threatening designer benzodiazepine

(2015) Magdalena Łukasik-Głębocka et al.   CLINICAL TOXICOLOGY

Next generation of novel psychoactive substances on the horizon – A complex problem to face

(2015) Jolanta B. Zawilska et al.   DRUG AND ALCOHOL DEPENDENCE

Polydrug abuse: A review of opioid and benzodiazepine combination use

(2012) Jermaine D. Jones et al.   DRUG AND ALCOHOL DEPENDENCE